Search results for: 'Cell and Gene Therapeutics Market'

16 Aug 2022  |  North America  |  Market Research

Global Cell and Gene Therapy (CGT) Growth Opportunities

The Shift to Prevalent Diseases and Allogeneic Cell Therapies Creates New Growth Opportunities in the CGT Value Chain

Infographics

×

This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approaches as well as investments and regulations. The study segments the market by product (cell therapy, gene-mod...

19 Aug 2022  |  North America  |  Market Research

Global Antibody Therapeutics Growth Opportunities

The Evolution of Next-generation Immuno-oncology Therapies for Multiple Tumor Antigens is Poised to Drive Market Growth

Infographics

×

Market growth is likely to be fueled by the growing utilization of cost-effective and efficient continuous manufacturing processes and single-use bioreactors for production, which will also reduce the time between development and commercialization. Favorable regulatory reforms in emerging Asian countries are encouraging the manufacture and introduc...

The study covers current and future market trends, drivers, challenges, and opportunities in US therapeutic apheresis market. It breaks down the market into hematology and oncology, neurology, rheumatology, and other therapeutic areas. Therapeutic apheresis has become an essential element of the blood and blood components industry value chain. Hosp...

Stem cell therapeutics are being developed in order to fill the gaps in medical care and offer beneficial treatments for diseases that are currently inadequately treated or for which no therapeutic options exist. The stem cell therapeutics market is still in its infancy; currently, there are no licensed stem cell products in the United States. Thi...

Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023. This report emp...

This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by special...

In recent years, single-cell analysis has changed rapidly. It began as a niche, specialized technology with few companies offering solutions, which then became commonly used in academia. Subsequently, its use has spread to areas such as biopharma, with more companies investing in the research and development (R&D) of single-cell analysis projects. ...

The global pharmaceutical industry is continuously evolving. with the rising need for novel therapies in the ever-changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as continuously growing number of cancer cases, market needs are shifting from traditional, small molecules to novel, large-molecule the...

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...